reports
Calavo Growers, Inc. Announces CFO Change in Leadership
Calavo Growers, Inc. Announces CFO Change in Leadership James Snyder to become Chief Financial Officer as Shawn Munsell Departs for New Role SANTA PAULA, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) -- (Nasdaq-GS: CVGW), a global leader in the processing and distribution of avocados, tomatoes, papayas, and guacamole, today announced that James Snyder will become the Company’s new Chief Financial Officer effective December 2. Shawn Munsell, Calavo’s current CFO will be departing the Company on November 29 to pursue a new opportunity. He will serve as a consultant to the Company in the month o...
Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and...
Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update High dose TSHA-102 was generally well tolerated with no SAEs or DLTs in two adolescent/adult patients and one pediatric patient as of data cutoff; IDMC approved continued enrollment in cohort two (high dose) across both REVEAL trials; eight patients dosed to date (low dose=4, high dose=4) Advanced discussions with the FDA on trial design, endpoints and potential use of established natural history dataset for Part B of REVEAL trials, and aligned on a meeting cadence to expedite the development p...
Taysha Gene Therapies to Release Third Quarter 2024 Financial Results ...
Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13 DALLAS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that it will report its financial results for the third quarter ended September 30, 2024, and host a corporate update conference call and webcast on Wednesday, November 13, 2024, at 4:30 PM East...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing ...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DALLAS, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on November 1, 2024, the Compensation Committee of Taysha's Board of Directors granted three new employees, in the aggregate, options to purchase 157,000 shares of the Company's common stock in connec...
Landmark Bancorp, Inc. Announces 30.5% Increase in Third Quarter Net E...
Landmark Bancorp, Inc. Announces 30.5% Increase in Third Quarter Net Earnings and Earnings Per Share of $0.72. Declares Cash Dividend of $0.21 per Share and 5% Stock Dividend Manhattan, KS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Landmark Bancorp, Inc. (“Landmark”; Nasdaq: LARK) reported diluted earnings per share of $0.72 for the three months ended September 30, 2024, compared to $0.55 per share in the second quarter of 2024 and $0.52 per share in the same quarter last year. Net earnings for the third quarter of 2024 amounted to $3.9 million, compared to $3.0 million in the prior quarter and $...
Landmark Bancorp, Inc. Announces Conference Call to Discuss Third Quar...
Landmark Bancorp, Inc. Announces Conference Call to Discuss Third Quarter 2024 Earnings Manhattan, KS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Landmark Bancorp, Inc. (Nasdaq: LARK) announced that it will release earnings for the third quarter of 2024 after the market closes on Wednesday, October 30, 2024. The Company will host a conference call to discuss these results on Thursday, October 31, 2024 at 10:00 am (CT). Investors may listen to the Company’s earnings call via telephone by dialing (833) 470-1428 and using access code 242414. Investors are encouraged to call the dial-in number at leas...
Taysha Gene Therapies to Present Biodistribution Data from an Analysis...
Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress Data from an analysis of five NHP studies showed lumbar IT administration led to widespread and consistent biodistribution of AAV9 gene therapy vectors across brain and spinal cord regions IT and ICM administration achieved comparable biodistribution across brain and spinal cord regions in NHPs Findings from the analysis reaffirm the clinical potential of IT administration as an effective, safe and minimally invasive approach to deliv...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing ...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DALLAS, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on October 1, 2024, the Compensation Committee of Taysha's Board of Directors granted one new employee an option to purchase 501,600 shares of the Company's common stock in connection with their employment. The stock option ...
Taysha Gene Therapies Announces Oral Presentation on TSHA-102 in Rett ...
Taysha Gene Therapies Announces Oral Presentation on TSHA-102 in Rett Syndrome at Upcoming 9th World Rett Syndrome Congress DALLAS, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that it will present previously disclosed clinical data on its TSHA-102 program in evaluation for Rett syndrome during an oral presentation at the upcoming 9th World R...
Calavo Growers, Inc. Announces Third Quarter 2024 Financial Results, D...
Calavo Growers, Inc. Announces Third Quarter 2024 Financial Results, Dividend Increase SANTA PAULA, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- (Nasdaq-GS: CVGW), a global leader in the processing and distribution of avocados, tomatoes, papayas, and guacamole, today reported its financial results for the fiscal third quarter ended July 31, 2024. Third Quarter Financial Overview Introductory Note: In the first quarter of 2024, we concluded that the Fresh Cut (formerly RFG) business meets the requirements to be classified as held for sale and discontinued operations. As a result, the finan...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing ...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DALLAS, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on September 3, 2024, the Compensation Committee of Taysha's Board of Directors granted one new employee an option to purchase 311,000 shares of the Company's common stock in connection with their employment. The stock opti...
Calavo Growers to Report Third Quarter Financial Results
Calavo Growers to Report Third Quarter Financial Results SANTA PAULA, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- (Nasdaq-GS: CVGW), a global leader in the avocado industry, today announced that it will release financial results for the fiscal third quarter ended July 31, 2024, after the market closes on Monday, September 9. About Calavo Growers, Inc.Calavo Growers, Inc. (Nasdaq-GS: CVGW) is a global leader in high quality produce, including avocados, tomatoes and papayas. Calavo products are sold under the trusted Calavo brand name, proprietary sub-brands, private label and store brands....
Calavo Growers Completes Sale of Fresh Cut Business
Calavo Growers Completes Sale of Fresh Cut Business SANTA PAULA, Calif., Aug. 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq-GS: CVGW), a global leader in the avocado industry, today announced that it completed the sale of its Fresh Cut business (formerly “RFG”) and related real estate to F&S Fresh Foods of Vineland, New Jersey, on August 15 for $83 million, subject to various closing adjustments. “We are pleased to announce that the sale of our Fresh Cut business has been finalized, which will allow us to focus on our core avocado and guacamole businesses,” said Lee Cole, President and Chief Exe...
Taysha Gene Therapies Reports Second Quarter 2024 Financial Results an...
Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update Presented cohort one (low dose) data from both trials of TSHA-102 at 2024 IRSF Rett Syndrome Scientific Meeting that demonstrated durable improvements across consistent clinical domains and an encouraging safety profile in adult (up to 52 weeks) and pediatric (up to 22 weeks) patients TSHA-102 was generally well tolerated with no SAEs or DLTs as of initial six-week assessment in first patient in cohort two (high dose) of adolescent/adult trial; IDMC approved dosing of second (adolescent/adult ...
Landmark Bancorp, Inc. Announces Second Quarter Earnings Per Share of ...
Landmark Bancorp, Inc. Announces Second Quarter Earnings Per Share of $0.55 Declares Cash Dividend of $0.21 per Share Manhattan, KS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Landmark Bancorp, Inc. (“Landmark”; Nasdaq: LARK) reported diluted earnings per share of $0.55 for the three months ended June 30, 2024, compared to $0.51 per share in the first quarter of 2024 and $0.61 per share in the same quarter last year. Net earnings for the second quarter of 2024 amounted to $3.0 million, compared to $2.8 million in the prior quarter and $3.4 million for the second quarter of 2023. For the three mon...
Taysha Gene Therapies to Release Second Quarter 2024 Financial Results...
Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12 DALLAS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that it will report its financial results for the second quarter ended June 30, 2024, and host a corporate update conference call and webcast on Monday, August 12, 2024, at 8:30 AM Eastern Time. ...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing ...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DALLAS, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on August 1, 2024, the Compensation Committee of Taysha's Board of Directors granted two new employees, in the aggregate, options to purchase 356,000 shares of the Company's common stock in connection with their employment. ...
- Jonathan Moreland
TCBI TEXAS CAPITAL BANCSHARES INC.
SIGI SELECTIVE INSURANCE GROUP INC.
SAIC SCIENCE APPLICATIONS INTERNATIONAL CORP.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
AMSWA AMERICAN SOFTWARE INC. CL A
ACRS ACLARIS THERAPEUTICS INC.
CULP CULP INC.
NAD NUVEEN QUALITY MUNICIPAL INCOM
EVBN EVANS BANCORP INC.
FRD FRIEDMAN INDUSTRIES INC.
UBFO UNITED SECURITY BANCSHARE
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
APPN APPIAN
PRPL PURPLE INNOVATION
FXNC INC.
REKR FIRST NATIONAL CORP. OF VIRGINIA
GRX REKOR SYSTEMS
AESE THE GABELLI HEALTHCARE & WELLNESSRX TRUST
TFC ALLIED ESPORTS ENTERTAINMENT
DMAC TRUIST FINANCIAL CORP
TSHA DIAMEDICA THERAPEUTICS INC.
TKNO TAYSHA GENE THERAPIES
AUID ALPHA TEKNOVA
IVFH INC.
ACHR IPSIDY INC.
ABIO INNOVATIVE FOOD HLDG
TPST ARCHER AVIATION INC
PET ARCA BIOPHARMA INC
KMPH MILLENDO THERAPEUTICS
BIGZ INC.
DOUG WAG GROUP CO
LCTC KEMPHARM INC
RH BLACKROCK INNOVATION AND GROWTH TST
LUXH DOUGLAS ELLIMAN INC
FCCND LIFELOC TECHNOLOGIES INC
NE RESTORATION HARDWARE HOLDINGS INC
STRW LUXURBAN HOTELS INC
ADCT SPECTRAL CAPITAL CORP
ASPI NOBLE CORP (NEW)
EP STRAWBERRY FIELDS REIT INC.
MIO ADC THERAPEUTICS SA
NUZE ASP ISOTOPES INC
BNED EMPIRE PETROLEUM CORP
DMA PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
ARDS NUZEE INC.
MXF BARNES & NOBLE EDUCATION INC.
SSKN DESTRA MULTI ALTERNATIVE FUND
ADVM ARIDIS PHARMACEUTICALS
NYC INC.
THE MEXICO FUND
INC.
STRATA SKIN SCIENCES INC.
ADVERUM BIOTECHNOLOGIES INC.
NEW YORK CITY REIT
INC.
Landmark Bancorp, Inc. Announces Conference Call to Discuss Second Qua...
Landmark Bancorp, Inc. Announces Conference Call to Discuss Second Quarter 2024 Earnings Manhattan, KS, July 16, 2024 (GLOBE NEWSWIRE) -- Landmark Bancorp, Inc. (Nasdaq: LARK) announced that it will release earnings for the second quarter of 2024 after the market closes on Monday, August 5, 2024. The Company will host a conference call to discuss these results on Tuesday, August 6, 2024 at 10:00 am (CT). Investors may listen to the Company’s earnings call via telephone by dialing (833) 470-1428 and using access code 974885. Investors are encouraged to call the dial-in number at least 5 mi...
- Jonathan Moreland
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
SAIC SCIENCE APPLICATIONS INTERNATIONAL CORP.
PSEC PROSPECT CAPITAL CORPORATION
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
NFBK NORTHFIELD BANCORP INC.
CVBF CVB FINANCIAL CORP.
CRMT AMERICA'S CAR-MART INC.
BEN FRANKLIN RESOURCES INC.
AMSWA AMERICAN SOFTWARE INC. CL A
ACRS ACLARIS THERAPEUTICS INC.
CLI MACK-CALI REALTY CORPORATION
NAD NUVEEN QUALITY MUNICIPAL INCOM
FRD FRIEDMAN INDUSTRIES INC.
XOM EXXON MOBIL CORPORATION
DMLP DORCHESTER MINERALS L.P.
NHF NEXPOINT CREDIT STRATEGIES FUN
CLIR CLEARSIGN TECHNOLOGIES CORP
LILA LIBERTY LATIN AMERICA A
PRPL PURPLE INNOVATION
VICR INC.
FXNC VICOR CORP.
REKR FIRST NATIONAL CORP. OF VIRGINIA
GOSS REKOR SYSTEMS
RZLT GOSSAMER BIO
ADV REZOLUTE
DMAC INC.
CSU ADVANTAGE SOLUTIONS INC (A)
TSHA DIAMEDICA THERAPEUTICS INC.
NUVB CAPITAL SENIOR LIVING
PFX TAYSHA GENE THERAPIES
AVTE NUVATION BIO INC (A)
AUID PHENIXFIN CORP
CLOV AEROVATE THERAPEUTICS
NSPR INC.
ACHR IPSIDY INC.
TPST CLOVER HEALTH INV CORP
ASLE INSPIREMD INC
BIGZ ARCHER AVIATION INC
DOUG MILLENDO THERAPEUTICS
LNKB INC.
RH AERSALE CORP
IRON BLACKROCK INNOVATION AND GROWTH TST
NE DOUGLAS ELLIMAN INC
ADCT LINKBANCORP INC
ASPI RESTORATION HARDWARE HOLDINGS INC
EP DISC MEDICINE INC
NUZE NOBLE CORP (NEW)
PEO ADC THERAPEUTICS SA
BNED ASP ISOTOPES INC
DMA EMPIRE PETROLEUM CORP
NRBO NUZEE INC.
ARDS PETROLEUM & RESOURCES CORPORATION
MXF BARNES & NOBLE EDUCATION INC.
DESTRA MULTI ALTERNATIVE FUND
NEUROBO PHARMACEUTICALS INC
ARIDIS PHARMACEUTICALS
INC.
THE MEXICO FUND
INC.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.